CTA
GILD icon

Colonial Trust Advisors’s Gilead Sciences GILD Stock Holding History

Colonial Trust Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53K Buy
420
+2
+0.5% +$264 ﹤0.01% 360
2026
Q1 		$58.3K Buy
418
+182
+77% +$25.5K ﹤0.01% 334
2025
Q4 		$29K Sell
236
-43
-15% -$5.23K ﹤0.01% 407
2025
Q3 		$31K Sell
279
-6
-2% -$682 ﹤0.01% 389
2025
Q2 		$31.6K Buy
285
+2
+0.7% +$213 ﹤0.01% 391
2025
Q1 		$31.8K Buy
283
+213
+304% +$22K ﹤0.01% 387
2024
Q4 		$6.47K Buy
70
+52
+289% +$4.68K ﹤0.01% 535
2024
Q3 		$1.51K Hold
18
– – ﹤0.01% 694
2024
Q2 		$1.24K Sell
18
-21
-54% -$1.4K ﹤0.01% 698
2024
Q1 		$2.86K Sell
39
-38
-49% -$2.92K ﹤0.01% 759
2023
Q4 		$6.24K Buy
77
+5
+7% +$389 ﹤0.01% 579
2023
Q3 		$5.4K Hold
72
– – ﹤0.01% 598
2023
Q2 		$5.55K Hold
72
– – ﹤0.01% 610
2023
Q1 		$5.97K Sell
72
-7
-9% -$580 ﹤0.01% 591
2022
Q4 		$6.78K Buy
+79
New +$6.26K ﹤0.01% 572

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Colonial Trust Advisors's GILD Position: Q2 2026 in Review

Colonial Trust Advisors increased its Gilead Sciences (GILD) stake by 0.48% in Q2 2026, buying an estimated $264 and bringing the position to 420 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #360.

Colonial Trust Advisors first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $58.3K in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Colonial Trust Advisors held 420 shares of Gilead Sciences worth $53K as of Q2 2026.
  • Colonial Trust Advisors bought 2 Gilead Sciences shares in Q2 2026, an estimated $264.
  • Gilead Sciences made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #360 holding.
  • Colonial Trust Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Colonial Trust Advisors's Gilead Sciences position peaked at $58.3K in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.